Bactrim Dosage for Skin Abscess
For adults with a drained skin abscess, prescribe trimethoprim-sulfamethoxazole (Bactrim) 1-2 double-strength tablets (160/800 mg) twice daily for 7 days. For children, use 8-12 mg/kg/day of the trimethoprim component divided into 2 doses daily for 7 days 1, 2.
Adult Dosing
The standard regimen is:
- 1-2 double-strength (DS) tablets (160/800 mg TMP/SMX) twice daily for 7 days 1
- This translates to 320-640 mg trimethoprim with 1600-3200 mg sulfamethoxazole per day
- The FDA label supports this dosing for skin and soft tissue infections 2
The higher dose (2 DS tablets = 320/1600 mg twice daily) is preferred based on the landmark randomized trial by Daum et al., which demonstrated superior outcomes with this regimen compared to placebo in 1,247 patients with drained abscesses 3. This study showed:
- Clinical cure: 92.9% vs 85.7% with placebo (P<0.001)
- Reduced need for repeat drainage: 3.4% vs 8.6%
- Fewer new infections at other sites: 3.1% vs 10.3%
Notably, a 2011 observational study found no difference in clinical resolution between high-dose (320/1600 mg) and standard-dose (160/800 mg) TMP-SMX 4, but the higher dose used in the definitive RCT 3 represents the strongest evidence.
Pediatric Dosing
For children over 2 months of age:
- 8-12 mg/kg/day based on trimethoprim component
- Divided into 2 doses daily (every 12 hours)
- Duration: 7 days 1, 2
Bactrim is contraindicated in infants under 2 months of age 2.
When to Use Antibiotics for Abscesses
The IDSA guidelines indicate antibiotics are appropriate for abscesses with 1, 5:
- Severe or extensive disease (multiple sites, rapid progression)
- Signs of systemic illness (fever, tachycardia)
- Associated cellulitis
- Immunosuppression
- Extremes of age
- Abscess in difficult-to-drain location
- Lack of response to incision and drainage alone
However, recent high-quality evidence suggests antibiotics provide benefit even for simple abscesses after drainage 3. The 2016 NEJM trial showed TMP-SMX reduced treatment failure by 7.2 percentage points and prevented complications across all patient subgroups, regardless of lesion size or traditional guideline criteria 6, 3.
Important Caveats
TMP-SMX lacks reliable streptococcal coverage, which is a limitation for non-purulent cellulitis 1. For purulent infections (abscesses), this is less concerning since Staphylococcus aureus (including MRSA) is the predominant pathogen 5, 3.
Gastrointestinal side effects occur more frequently than placebo (mostly mild nausea), but are less severe than with clindamycin, which carries substantially higher risk of diarrhea (OR 2.71) 7.
Clindamycin (300-450 mg four times daily) is an alternative with similar efficacy to TMP-SMX for wound infections 8, though it may have lower recurrence rates (2.0% vs 7.1% at 6-8 weeks). However, concerns about inducible resistance in MRSA and C. difficile risk make TMP-SMX the preferred first-line agent 1, 5.
Treatment duration is 7 days for uncomplicated abscesses, which can be extended to 10-14 days for more severe infections 1, 5.